Working... Menu

Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC (TRIBE2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02339116
Recruitment Status : Active, not recruiting
First Posted : January 15, 2015
Last Update Posted : January 16, 2019
Information provided by (Responsible Party):
Gruppo Oncologico del Nord-Ovest